rs797046038

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PM4_SupportingBP6BS1BS2

The NM_001082538.3(TCTN1):​c.702_704delTAA​(p.Asn235del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.003 in 1,613,986 control chromosomes in the GnomAD database, including 8 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 7 hom. )

Consequence

TCTN1
NM_001082538.3 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: 5.66

Publications

2 publications found
Variant links:
Genes affected
TCTN1 (HGNC:26113): (tectonic family member 1) This gene encodes a member of a family of secreted and transmembrane proteins. The orthologous gene in mouse functions downstream of smoothened and rab23 to modulate hedgehog signal transduction. This protein is a component of the tectonic-like complex, which forms a barrier between the ciliary axoneme and the basal body. A mutation in this gene was found in a family with Joubert syndrome-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
HVCN1 (HGNC:28240): (hydrogen voltage gated channel 1) This gene encodes a voltage-gated protein channel protein expressed more highly in certain cells of the immune system. Phagocytic cells produce superoxide anions which require this channel protein, and in B cells this same process facilitates antibody production. This same channel protein, however, can also regulate functions in other cells including spermatozoa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_001082538.3. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 12-110632544-GATA-G is Benign according to our data. Variant chr12-110632544-GATA-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 212385.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00171 (260/152310) while in subpopulation NFE AF = 0.00331 (225/68028). AF 95% confidence interval is 0.00295. There are 1 homozygotes in GnomAd4. There are 117 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TCTN1NM_001082538.3 linkc.702_704delTAA p.Asn235del disruptive_inframe_deletion Exon 5 of 15 ENST00000397659.9 NP_001076007.1 Q2MV58-2B4DIB9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TCTN1ENST00000397659.9 linkc.702_704delTAA p.Asn235del disruptive_inframe_deletion Exon 5 of 15 1 NM_001082538.3 ENSP00000380779.4 Q2MV58-2
TCTN1ENST00000551590.5 linkc.702_704delTAA p.Asn235del disruptive_inframe_deletion Exon 5 of 15 1 ENSP00000448735.1 Q2MV58-1
TCTN1ENST00000397655.7 linkc.702_704delTAA p.Asn235del disruptive_inframe_deletion Exon 5 of 15 1 ENSP00000380775.3 Q2MV58-3
TCTN1ENST00000397656.8 linkn.*335_*337delTAA non_coding_transcript_exon_variant Exon 6 of 16 2 ENSP00000380776.4 J3KPW2
TCTN1ENST00000480648.5 linkn.702_704delTAA non_coding_transcript_exon_variant Exon 5 of 16 5 ENSP00000437196.1 E9PNE4
TCTN1ENST00000495659.6 linkn.*460_*462delTAA non_coding_transcript_exon_variant Exon 5 of 15 2 ENSP00000436673.2 E9PIB8
TCTN1ENST00000397656.8 linkn.*335_*337delTAA 3_prime_UTR_variant Exon 6 of 16 2 ENSP00000380776.4 J3KPW2
TCTN1ENST00000495659.6 linkn.*460_*462delTAA 3_prime_UTR_variant Exon 5 of 15 2 ENSP00000436673.2 E9PIB8

Frequencies

GnomAD3 genomes
AF:
0.00171
AC:
260
AN:
152192
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00331
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00160
AC:
400
AN:
249536
AF XY:
0.00154
show subpopulations
Gnomad AFR exome
AF:
0.000323
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000418
Gnomad NFE exome
AF:
0.00333
Gnomad OTH exome
AF:
0.000825
GnomAD4 exome
AF:
0.00313
AC:
4576
AN:
1461676
Hom.:
7
AF XY:
0.00297
AC XY:
2158
AN XY:
727174
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33466
American (AMR)
AF:
0.000112
AC:
5
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86248
European-Finnish (FIN)
AF:
0.000805
AC:
43
AN:
53388
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00398
AC:
4424
AN:
1111882
Other (OTH)
AF:
0.00154
AC:
93
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
244
488
733
977
1221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00171
AC:
260
AN:
152310
Hom.:
1
Cov.:
32
AF XY:
0.00157
AC XY:
117
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000553
AC:
23
AN:
41560
American (AMR)
AF:
0.000261
AC:
4
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00331
AC:
225
AN:
68028
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000613
Hom.:
0
Bravo
AF:
0.00156
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00294
EpiControl
AF:
0.00207

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Oct 21, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The TCTN1 p.Asn235del variant was not identified in the literature nor was it identified in LOVD 3.0. The variant was identified in dbSNP (ID: rs1179582623) and ClinVar (classified as uncertain significance by Genetic Services Laboratory, University of Chicago, EGL Genetic Diagnostics and GeneDx, and as likely benign by Invitae). The variant was identified in control databases in 455 of 280942 chromosomes (2 homozygous) at a frequency of 0.00162 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (non-Finnish) in 420 of 128690 chromosomes (freq: 0.003264), Other in 7 of 7148 chromosomes (freq: 0.000979), European (Finnish) in 12 of 25030 chromosomes (freq: 0.000479), African in 11 of 24202 chromosomes (freq: 0.000455) and Latino in 5 of 35374 chromosomes (freq: 0.000141), but was not observed in the Ashkenazi Jewish, East Asian, or South Asian populations. This variant is an in-frame deletion resulting in the removal of a asparagine (asn) residue at codon 235; the impact of this alteration on TCTN1 protein function is not known. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

Sep 04, 2018
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

A variant of uncertain significance has been identified in the TCTN1 gene. The c.702_704delTAA variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.702_704delTAA variant is observed in 168/66,738 (0.3%) alleles from individuals of European background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The c.702_704delTAA results in an in-frame deletion of a single Asparagine residue, denoted p.Asn235del. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -

TCTN1-related disorder Benign:1
Feb 03, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not specified Benign:1
Feb 08, 2021
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 19, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Meckel-Gruber syndrome;C0431399:Joubert syndrome Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
5.7
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs797046038; hg19: chr12-111070349; COSMIC: COSV108920815; COSMIC: COSV108920815; API